Literature DB >> 15326268

Melatonin, 3 mg, is effective for migraine prevention.

M F P Peres1, E Zukerman, F da Cunha Tanuri, F R Moreira, J Cipolla-Neto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15326268     DOI： 10.1212/01.wnl.0000134653.35587.24

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  26 in total

1.  Arctic environment triggers migraine attacks.

Authors:  Hallvard Lilleng; Svein Ivar Bekkelund
Journal:  Can Fam Physician       Date:  2010-06       Impact factor: 3.275

2.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

Review 3.  Current and investigational drugs for the prevention of migraine in adults and children.

Authors:  Frederick G Freitag; Derrick Shumate
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

Review 4.  Role of melatonin in the pathophysiology of migraine: implications for treatment.

Authors:  Barbara Vogler; Alan M Rapoport; Stewart J Tepper; Fred Sheftell; Marcelo E Bigal
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

Authors:  Fabiano C Tanuri; Eliângela de Lima; Mario F P Peres; Francisco R Cabral; Maria da Graça Naffah-Mazzacoratti; Esper Abrão Cavalheiro; José Cipolla-Neto; Eliova Zukerman; Débora Amado
Journal:  J Headache Pain       Date:  2009-01-27       Impact factor: 7.277

6.  Melatonin to prevent migraine or tension-type headache in children.

Authors:  Silvia Miano; Pasquale Parisi; Andrea Pelliccia; Anna Luchetti; Maria Chiara Paolino; Maria Pia Villa
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

7.  Headache in pregnancy.

Authors:  Dawn A Marcus
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

8.  Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study.

Authors:  Anastasia Bougea; Nikolaos Spantideas; Vasilis Lyras; Theodoros Avramidis; Thomas Thomaidis
Journal:  Funct Neurol       Date:  2016 Jan-Mar

Review 9.  Melatonin for the treatment of irritable bowel syndrome.

Authors:  Kewin Tien Ho Siah; Reuben Kong Min Wong; Khek Yu Ho
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.

Authors:  Bernadett Tuka; Aliz Nyári; Edina Katalin Cseh; Tamás Körtési; Dániel Veréb; Ferenc Tömösi; Gábor Kecskeméti; Tamás Janáky; János Tajti; László Vécsei
Journal:  J Headache Pain       Date:  2021-06-25       Impact factor: 7.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.